Abnormal turning behaviour, GABAergic inhibition and the degeneration of astrocytes in ovine Tribulus terrestris motor neuron disease

Australian Veterinary Journal

Volumn 84, Issue 1-2, 2006, Pages 53-58

  Bourke, C A ^a  

^a NSW DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; OVIS; OVIS ARIES; TRIBULUS; TRIBULUS TERRESTRIS; WALLERIA;

EID: 33645738058     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2006.tb13128.x     Document Type: Article

References (24)

1. Bourke CA. Staggers in sheep associated with the ingestion of Tribulus terrestris. Aust Vet J 1984;61:360-363.
2. Bourke CA. A novel nigrostriatal dopaminergic disorder in sheep affected by Tribulus terrestris staggers. Res Vet Sci 1987;43:347-350.
3. Bourke CA. Taxonomic, agronomic, and animal health aspects of Tribulus. Proceedings, 8th Australian Weeds Conference 1987:182-185.
4. Wilson KL. In: Harden GJ, editor, Flora of New South Wales, vol 3. New South Wales University Press, Kensington 1992:12-13.
5. Bourke CA, Carrigan MJ, Dixon RJ. Upper motor neurone effects in sheep of some beta-carboline alkaloids identified in zygophyllaceous plants. Aust Vet J 1990;67:248-251.
6. Bourke CA, Stevens GR, Carrigan MJ. Locomotor effects in sheep of alkaloids identified in Australian Tribulus terrestris. Aust Vet J 1992;69:163-165.
7. Latch GCM. Physiological interactions of endophytic fungi and their hosts. Agric Ecosyst Environ 1993;44:143-156.
8. DeLorey TM, Olsen RW. In: Siegal GJ, Agranoff BW, Albers RW, Molinoff PB, editors, Basic Neurochemistry, 5th edn. Raven Press, New York 1994:389-399.
9. Kopin IJ. In: Siegal GJ, Agranoff BW, Albers RW, Molinoff PB, editors. Basic Neurochemistry, 5th edn, Raven Press, New York 1994:899-918.
10. Bourke CA. The clinical differentiation of nervous and muscular locomotor disorders of sheep in Australia. Aust Vet J 1995;72:228-234.
11. Click SD, Jerussi TP, Zimmerberg B. In: Harnard S, Doty RW, Goldstein L, Jaynes J, Krauthamer G, editors. Lateralization in the nervous system. Academic Press, New York, 1977:213-249.
12. Walker SF. Lateralization of functions in the vertebrate brain. Br J Psychol 1980;71:329-367.
13. Biswas B, Carlsson A. On the mode of action of diazepam on brain catecholamine metabolism. Naunyn-Schmiedaberg's Arch Pharmacol 1978;303:73-78.
14. Bunney BS, Aghajanian GK. The effect of antipsychotic drugs on the firing of dopaminergic neurones. In: Wenner-Gren Centre International Symposium Series. Pergamon Press, Oxford 1974;25:305-318.
15. Hedler L, Stamm G, Weitzell R, Starke K. Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers. Eur J Pharmacol 1981;70:43-52.
16. Lillie RD, Fulmer HM. In: Histopathologic Technic and Practice, Histiochemistry, 4th edn. McGraw-Hill, New York 1976:522-527.
17. Kim Jh, Vezina P. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. J Pharmacol Exp Therap 1997;283:962-968.
18. Dybdal D, Gale K. Postural and anticonvulsant effects of inhibition of the rat subthalamic nucleus. J Neurosci 2000;20:6728-6733.
19. Speller JM, Westbury GWM. Bicuculline-induced circling from the rat superior colliculus is blocked by GABA microinjection into the deep cerebellar nuclei. Exp Brain Res 1996;110:425-434.
20. Frizzo MES, Lara DR, Dahm KSC et al. Activation of glutamate uptake by guanosine in primary astrocyte cultures. Neuroreport 2001;12:879-881.
21. Nishizaki T. ATP- and adenosine- mediated signalling in the central nervous system. J Pharmacol Sci 2004;94:100-102.
22. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocrine Rev 1993;14:222-240.
23. Linden J. In: Siegal GJ, Agranoff BW, Albers RW, Molinoff PB, editors. Basic Neurochemistry, 5th edn. Raven Press, New York 1994:401-416.
24. Traversa U, Bombi G, Di Iorio P et al. Specific guanosine binding sites in rat brain membranes. Br J Pharmacol 2002;135:969-976.